In focal segmental glomerulosclerosis (FSGS), the JAK–STAT signaling pathway is activated, with increased phosphorylation of STAT1 and STAT3 in both the glomerulus and renal tubulointerstitium [16]. Here, STAT1 is linked to focal segmental glomerulosclerosis.